HLA DRB1*13 as a Risk Factor for Type 1 Autoimmune Hepatitis in North American Patients

2007 ◽  
Vol 53 (2) ◽  
pp. 522-528 ◽  
Author(s):  
Albert J. Czaja ◽  
Herschel A. Carpenter ◽  
S. Breanndan Moore
2007 ◽  
Vol 28 (2) ◽  
pp. 198-201 ◽  
Author(s):  
Priscilla Biller ◽  
Beth Shank ◽  
Leah Lind ◽  
Meghan Brennan ◽  
Lisa Tkatch ◽  
...  

An outbreak ofClostridium difficile-associated disease (CDAD) caused by the epidemic North American pulsed-field gel electrophoresis type 1 (NAP1) strain began after a formulary change from levofloxacin to moxifloxacin. Cases of CDAD were associated with moxifloxacin use, but a formulary change back to levofloxacin failed to reduce rates of disease. Substituting use of one fluoroquinolone with use of another without also controlling the overall use of drugs from this class is unlikely to control outbreaks caused by the NAP1 strain ofC. difficile.


2006 ◽  
Vol 26 (5) ◽  
pp. 552-558 ◽  
Author(s):  
Albert J. Czaja ◽  
Herschel A. Carpenter ◽  
S. Breanndan Moore

2014 ◽  
Vol 45 (6) ◽  
pp. 638-644 ◽  
Author(s):  
Atsushi Takahashi ◽  
Hiromasa Ohira ◽  
Kazumichi Abe ◽  
Yasuhiro Miyake ◽  
Masanori Abe ◽  
...  

2006 ◽  
Vol 38 (9) ◽  
pp. A83-A84
Author(s):  
A. Vannini ◽  
A.J.W. Zendman ◽  
A.C. Dall’Aglio ◽  
G. Ballardini ◽  
D. Zauli ◽  
...  

Author(s):  
Maaike Biewenga ◽  
Xavier P.D.M.J. Verhelst ◽  
Martine A.M.C. Baven‐Pronk ◽  
Hein Putter ◽  
Aad P. Berg ◽  
...  

2016 ◽  
Vol 27 (9) ◽  
pp. 1059-1066 ◽  
Author(s):  
Hisayoshi Kondo ◽  
Midori Soda ◽  
Norie Sawada ◽  
Manami Inoue ◽  
Yoshitaka Imaizumi ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document